Renal carcinoma with (6;11)(p21;q12) translocation: Report of an adult case

Pathology International

Volumn 61, Issue 9, 2011, Pages 539-545

  Ishihara, Akira ^a   Yamashita, Yasuhiro ^a   Takamori, Hiroki ^a   Kuroda, Naoto ^b  

^a Nobeoka Prefectural Hospital   (Japan)

^b KOCHI RED CROSS HOSPITAL   (Japan)

Author keywords

MiTF TFE family translocation renal carcinomas; Multi kinase inhibitor; Sunitinib malate; T(6; 11)(p21; q12); Temsirolimus; Transcription factor EB (TFEB)

Indexed keywords

CATHEPSIN K; CYTOKERATIN AE1; CYTOKERATIN AE3; MELAN A; MONOCLONAL ANTIBODY HMB 45; OPIATE; PROTEIN S 100; SUNITINIB; TEMSIROLIMUS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTRO EB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACKACHE; CALCIFICATION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 6P21; HUMAN; IMMUNOREACTIVITY; KIDNEY CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MOLECULARLY TARGETED THERAPY; NEPHRECTOMY; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; CATHEPSIN K; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; INTERFERONS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PYRROLES; SIROLIMUS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 80052266521     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02711.x     Document Type: Article

References (19)

1. Camparo P, Vasiliu V, Molinie V etal. Renal translocation carcinomas. Clinicopathologic, immunohistochemical, and gene expression profiling. Analysis of 31 cases with a review of the literature. Am J Surg Pathol 2008; 35: 656-70.
2. Argani P, Antonescu CR, Illei PB etal. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159: 179-92.
3. Clark J, Lu YJ, Sidhar SK etal. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997; 15: 2233-9.
4. Argani P, Hawkins A, Griffin CA etal. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol 2001; 158: 2089-96.
5. Kuiper RP, Schepens M, Thijssen J etal. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet 2003; 12: 1661-9.
6. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization Classification of Tumours; Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004.
7. Argani P, Lae M, Hutchinson B etal. Renal carcinomas with the t(6;11)(p21;q12). Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol 2005; 29: 230-40.
8. Pacciarini L, Cangi MG, Cunsolo CL etal. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes Chromosomes Cancer 2007; 46: 419-26.
9. Martignoni G, Pea M, Gobbo S etal. Cathepsin-K immunoreactivity distinguishes MiTF/FFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol 2009; 22: 1016-22.
10. Martignoni G, Tardanico R, Pea M etal. t6; 11 renal cell tumor. A clinicopathologic study of 2 cases in adults. Annual meeting abstracts. Mod Pathol 2005; 18: 715.
11. Zhan HQ, Wang CF, Zhu XZ etal. Renal cell carcinoma with t(6;11) translocation: A patient case with a novel Alpha-TFEB fusion point. J Clin Oncol 2010; 28: e709-e713.
12. Dijkhuizen T, van den Berg E, Strorkel S etal. Two cases of renal cell carcinoma, clear cell type, revealing a t(6;11)(p21;q13). Cancer Genet Cytogenet 1996; 91: 141.
13. Davis IJ, His BL, Arroyo JD etal. Cloning of an Alpha-TFEB fusion in renal tumours horboring the t(6;11)(p21; q13) chromosome translocation. Proc Natl Acad Sci USA 2003; 100: 6051-6.
14. Gelleraji, Argani P, Adeniran A etal. Translocation renal cell carcinoma: Lack of negative impact due to lymph node spread. Cancer 2008; 112: 1607-16.
15. Hora M, Hes O, Ulge T etal. A distinctive translocation carcinoma of the kidney ['rosette-like forming, ' t(6;11), HMB45-positive renal tumor]. Int Urol Nephrol 2009; 41: 553-7.
16. Suarez-Vilela D, Izquierdo-Garcia F, Mendez-Alvatez JR etal. Renal translocation carcinoma with expression of TFEB. Presentation of a case with distinctive histological and immunohistochemical features. Int J Surg Pathol. [epub ahead of print on August 16, 2009].
17. US Food and Drug Administration. 2006. FDA approves new treatment for gastrointestinal and kidney cancer. January 26.
18. Figlin RA, Hutson TE, Tomczak P etal. Overall survival with sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC). Abstract no. 5024. Annual Meeting of American Society of Clinical Oncology 2008.
19. A phase 2 study of ARQ 197 in patients with microphthalmia transcription factor associated tumors. Available from:.